IKENA ONCOLOGY, INC.

Analyst Reco. Ikena Oncology, Inc.

Equities

IKNA

US45175G1085

Market Closed - Nasdaq Other stock markets 01:30:00 02/07/2024 am IST			5-day change	1st Jan Change
1.65 ^USD	0.00%		-1.79%	-16.24%

29/05	HC Wainwright Adjusts Price Target on Ikena Oncology to $4 From $11, Maintains Buy Rating	MT
29/05	Wedbush Downgrades Ikena Oncology to Neutral From Outperform After Discontinuation of Lead Program IK-930, Adjusts PT to $2 From $8	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HC Wainwright Adjusts Price Target on Ikena Oncology to $4 From $11, Maintains Buy Rating	29/05	MT
Wedbush Downgrades Ikena Oncology to Neutral From Outperform After Discontinuation of Lead Program IK-930, Adjusts PT to $2 From $8	29/05	MT
HC Wainwright Adjusts Ikena Oncology Price Target to $11 From $18, Maintains Buy Rating	10/11	MT
Wedbush Lowers Ikena Oncology's Price Target to $8 From $11, Moves Estimates Launch Timings for IK-930; Maintains Outperform Rating	10/11	MT
Wedbush Starts Ikena Oncology at Outperform With $11 Price Target	22/23/22	MT
Credit Suisse Adjusts Ikena Oncology's Price Target to $13 From $16, Keeps Outperform Rating	15/23/15	MT
Credit Suisse Adjusts Ikena Oncology's Price Target to $16 From $18, Keeps Outperform Rating	29/22/29	MT
HC Wainwright Adjusts Ikena Oncology's Price Target to $22 From $26, Keeps Buy Rating	29/22/29	MT
Credit Suisse Lowers Ikena Oncology's Price Target to $18 From $20, Keeps Outperform Rating	08/22/08	MT
Credit Suisse Lowers Ikena Oncology's Price Target to $20 from $24, Keeps Outperform Rating	13/22/13	MT
HC Wainwright Adjusts Price Target on Ikena Oncology to $26 From $25, Reiterates Buy Rating	13/22/13	MT
History shows stocks can weather rate hike cycle	16/22/16	RE
HC Wainwright Initiates Coverage on Ikena Oncology With Buy Rating, $25 Price Target	23/21/23	MT
IKENA ONCOLOGY : Credit Suisse Lowers Ikena Oncology's Price Target to $27 From $30 on Expense, Forecast Adjustments; Outperform Rating Kept	13/21/13	MT
IKENA ONCOLOGY : Cowen Initiates Ikena Oncology With Outperform Rating	20/21/20	MT
IKENA ONCOLOGY : William Blair Initiates Ikena Oncology at Outperform Rating	20/21/20	MT
IKENA ONCOLOGY : Credit Suisse Starts Ikena Oncology at Outperform with $30 Price Target, Notes 'Attractive' Novel Cancer Therapy Candidates	20/21/20	MT
IKENA ONCOLOGY : Jefferies Initiates Coverage on Ikena Oncology With Buy Rating	20/21/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer